BSD Medical Corporation | Return to Homepage
Home    |    Contact us    |    Terms of Use    |    Privacy Statement    |    Site Map        
BSD Medical -- Delivering Thermal Energy to Medicine
About BSD Medical Products For Patients For Healthcare Professionals Investor Relations

Press Releases

  • 1/29/15 10:50 am MST
    • Submits non-binding term sheet for hyperthermia assets

    • Commences monetization of real estate assets

    • Expects 180-day grace period extension from NASDAQ

    BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today provided an update on its strategic plan for the Company first outlined on January 12, 2015.  As part of this plan, BSD intends to exit its hyperthermia product line this year and has submitted a non-binding term sheet for the potential sale of its assets.  Terms are still being negotiated; however, the Company expects to close the transactionmore...
  • 1/15/15 7:20 am MST

    Investor & Analyst Conference Call Today at 2:00 p.m. Eastern Time/12:00 p.m. Mountain Time

    BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today reported financial results for the fiscal first quarter of 2015 ended November 30, 2014. Total revenues were $843,168 for the first quarter ended November 30, 2014, a decrease of 37% compared to total revenues of $1,330,645 for the three months ended November 30, 2013.  Product sales in the three months ended November 30, 2013 includedmore...
  • 1/12/15 7:21 am MST

    Investor & Analyst Conference Call Scheduled for Thursday, January 15 at 2:00 p.m. Eastern Time/12:00 p.m. Mountain Time; RSVP Required

    BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced its strategic plans and initial revenue targets for the upcoming three-year period. The announcement was made in advance of investor and analyst meetings BSD management is holding this week in the San Francisco Bay Area, concluding with an Investor & Analyst Update Call on Thursday, January 15, 2015 at 2:00 p.m. Eastern time/12:00 p.mmore...
  • 12/29/14 8:31 am MST

    Live Conference Call and Webcast Scheduled for Thursday, January 15 at 2:00 p.m. Eastern Time/12:00 p.m. Mountain Time; RSVP Required

    Salt Lake City – December 29, 2014 – BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that BSD’s new CEO, Clint Carnell, will host an Investor & Analyst Update Call outlining BSD’s three year strategic vision on Thursday, January 15, 2015 at 2:00 p.m. Eastern time/12:00 p.m. Mountain time.Individuals interested in listening to the conference call may do so by visiting the Investormore...
  • 11/13/14 7:15 am MST
    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a provider of medical systems that treat cancer and benign diseases using heat therapy, today reported financial results for its fiscal year ended August 31, 2014. Financial Highlights for Fiscal Year 2014 Total revenues of $5.3 million, a $1.6 million increase from $3.7 million for fiscal year 2013 Total stockholders’more...
  • 11/12/14 7:15 am MST
    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, announced today that in connection with Mr. Carnell’s appointment, the Company and Mr. Carnell have agreed on an employment offer that provides in part that Mr. Carnell will be issued an inducement equity award outside the Company's Stock Incentive Plan in accordance with the NASDAQmore...
  • 11/10/14 6:30 am MST

    Brings Track Record of Proven Leadership and Commercial Success

    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that its Board of Directors has appointed Clint Carnell, 45, President, Chief Executive Officer, and member of the Board of Directors, effective immediately. Carnell succeeds Harold (Butch) R. Wolcott, who announced in April 2014 his intent to step down as CEO upon the hiring of a successormore...
  • 10/24/14 7:15 am MDT
    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, announced today that Drs. JY Gaubert, P Chevallier, and V Vidal, leading French researchers, presented the successful results of their animal study utilizing the MicroThermX® Microwave Ablation System (MicroThermX) at CIRSE 2014. The study was sponsored by Terumo Europe N.V. The objectivemore...
  • 10/15/14 7:15 am MDT

    Signs Distribution Agreement with KOL Bio-Medical Instruments, Inc.

    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, announced today that the company has signed an agreement with KOL Bio-Medical Instruments, Inc. (KOL) for the sales and distribution of BSD’s MicroThermX® Microwave Ablation (MicroThermX) line of products. KOL sales and distribution area will include up to 15 states in the Northeast, Mid-more...
  • 9/29/14 7:15 am MDT

    Creates Sales Pathway for BSD-2000 in Largest and Most Receptive Hyperthermia End-Market in the World

    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, announced today that BSD’s exclusive distributor in the People’s Republic of China, Dalian Orientech Co. LTD (“Orientech”), has informed BSD that China’s Food and Drug Administration (the “CFDA”) has approved and renewed the marketing and import license application for the BSD-2000more...


Business Wire InvestorHQ℠